From: Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107
Healthy donors
MS patients
n
24
32
Female/male
19/5
23/9
Age (mean ± SE)
36.4 ± 3.2
40.1 ± 2.5
Disease duration (mean ± SE)
--
7.4 ± 1.1
EDSS (mean ± SE)
2.2 ± 0.3